Symvivo Corporation Is A Clinical Stagebiotechnology Company Based In Burnabybritish Columbiacanadathecompany Focuses On Advancing Its Proprietary Bactrla C Platformwhich Enables Sitespecific Delivery Of Genes To Treat And Prevent Lifethreatening Diseasesthis Platform Allows For Theoral And Intravenous Delivery Of Plasmid Dnaenabling Patientscells To Producetherapeutic Proteinssymvivo S Technology Is Applicablein Various Fieldsincluding Oral Dna Vaccinesoncologyimmunologyand Protein Therapy Symvivo Is Actively Developing Oral Dna Vaccines That Utilizethebody S Own Cells To Generateantigensthecompany Is Also Engaged In Oncology Research With Ongoing Clinical Trials And Applies Its Platform In Immunology To Enhanceimmuneresponsesadditionallysymvivo Collaborates With Major Pharmaceutical Companies Likejanssen And Merckfocusing On Advancing Its Technology And Exploring New Therapeutic Avenuesthesepartnerships Highlight Symvivo S Commitment To Innovation In Genedelivery Technology
